Language Select
Varian Logo

Press Releases

Februar 06, 2019
Varian (NYSE: VAR) today announced its Eclipse™ treatment planning system and TrueBeam® treatment system have been named Category Leaders in the 2019 Best in KLAS: Software and Services Report... Read more
Februar 05, 2019
Varian (NYSE: VAR) today announced it will be demonstrating a portfolio of smarter cancer care software solutions, February 12-14 in Orlando, FL at HIMSS19, booth 6143. Envisioning a world without... Read more
Januar 23, 2019
First Quarter 2019 Summary – Oncology gross orders grew 16% in dollars, or 17% in constant currency – Total company revenues grew 9% in dollars, or 10% in constant currency, to $741 million... Read more
Januar 21, 2019
Varian (NYSE: VAR) today announced the installation of the gantry for the Varian ProBeam® Compact single-room proton therapy system at the new oncology center at Biopolis, an international... Read more
Januar 17, 2019
Varian (NYSE: VAR) announced 10 patients at the Chi Mei Medical Center with brain lesions became the first patients in Taiwan to be treated using the company's HyperArc™ High Definition... Read more
Januar 14, 2019
With nearly 1,300 Chinese radiation oncology professionals in attendance and an additional 8,000 users watching via a live webcast, Varian (NYSE: VAR) recently held its 2019 China Users Meeting in... Read more
Dezember 24, 2018
Varian (NYSE: VAR) today announced it received notification from the United States Trade Representative (USTR) that its exclusion request for Halcyon™ radiotherapy systems for cancer treatments,... Read more
Dezember 19, 2018
Varian (NYSE: VAR) today announced that Dow Wilson, chief executive officer, and Chris Toth, president of Oncology Systems, will present at the J.P. Morgan Healthcare Conference in San Francisco,... Read more
Dezember 18, 2018
Varian (NYSE: VAR) announced the Phoenix Cyberknife and Radiation Oncology Center in Phoenix, AZ recently completed its first HyperArc™ High Definition Radiotherapy (HDRT) treatments for two... Read more
Dezember 11, 2018
Varian (NYSE: VAR) today announced the Paul Scherrer Institute (PSI) Center for Proton Therapy in Switzerland has begun utilizing Varian's Eclipse treatment planning system for intensity modulated... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com